Welsh Centre for Emergency Medicine Research, Swansea University, Morriston Hospital, Abertawe Bro Morgannwg University Health Board, Swansea, UK.
Morriston Cardiac Centre, Morriston Hospital, Abertawe Bro Morgannwg University Health Board, Swansea, UK.
Clin Hemorheol Microcirc. 2019 Jul 27;-1:147-153. doi: 10.3233/CH-190615.
This aim of this study is to investigate the individual effects of varying concentrations of thrombin and fibrinogen on clot microstructure (characterised through the fractal dimension of the incipient clot network, df) and clot formation time (TGP) using a fibrin-thrombin clot model. df and TGP markers are measured using a haemorheological method that has already been investigated for whole blood.
This is an in vitro study using three thrombin concentrations (0.1, 0.05 and 0.02 NIH/ml) and two fibrinogen concentrations (8 mg/ml and 12 mg/ml) to investigate a fibrin-thrombin clot model. The haemorheological changes were measured at the gel point using df and TGP.
Fractal dimension (df) increased with increasing concentrations of thrombin both at 8 mg/ml (1.60±0.024, 1.67±0.022, 1.74±0.079) and 12 mg/ml fibrinogen concentrations (1.63±0.02, 1.87±0.019, 1.95±0.014). On the other hand, TGP decreased for both 8 mg/ml (1089±265, 637±80, 223±22 seconds) and 12 mg/ml fibrinogen concentrations (2008±247, 776±20, 410±20 seconds). In contrast to previous studies investigating whole blood, TGP increased with higher fibrinogen levels.
The findings from this fibrin-thrombin clot model confirmed that df and TGP can detect changes in the incipient clot following manipulation of fibrinogen and thrombin concentration. df increases (indicating stronger clot) with higher concentrations of thrombin and fibrinogen. On the other hand, TGP decreased as expected with higher thrombin level but not with higher fibrinogen concentrations.
本研究旨在通过纤维蛋白-凝血酶凝块模型,研究不同浓度的凝血酶和纤维蛋白原对凝块微观结构(通过初生凝块网络的分形维数 df 来表征)和凝块形成时间(TGP)的个体影响。df 和 TGP 标志物是使用已经针对全血进行过研究的血液流变学方法测量的。
这是一项使用三种凝血酶浓度(0.1、0.05 和 0.02 NIH/ml)和两种纤维蛋白原浓度(8mg/ml 和 12mg/ml)的体外研究,用于研究纤维蛋白-凝血酶凝块模型。在凝胶点使用 df 和 TGP 测量血液流变学变化。
在 8mg/ml 纤维蛋白原浓度下,df 随着凝血酶浓度的增加而增加(1.60±0.024、1.67±0.022、1.74±0.079),在 12mg/ml 纤维蛋白原浓度下也是如此(1.63±0.02、1.87±0.019、1.95±0.014)。另一方面,对于两种纤维蛋白原浓度(8mg/ml:1089±265、637±80、223±22 秒;12mg/ml:2008±247、776±20、410±20 秒),TGP 均降低。与先前研究全血的研究相反,TGP 随着纤维蛋白原水平的升高而增加。
该纤维蛋白-凝血酶凝块模型的研究结果证实,df 和 TGP 可以检测纤维蛋白原和凝血酶浓度变化后初生凝块的变化。df 随着凝血酶和纤维蛋白原浓度的升高而增加(表明凝块更强)。另一方面,随着凝血酶水平的升高,TGP 如预期的那样降低,但随着纤维蛋白原浓度的升高则没有降低。